ctrl K

AI Score

Unlock

Olema Pharmaceuticals Inc... (OLMA)

AI Score

Unlock

4.21

-0.16 (-3.66%)

At close: Mar 03, 2025, 3:59 PM

4.21

-0.12%

After-hours: Mar 03, 2025, 04:00 PM EST

Olema Pharmaceuticals Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	377K	1.66M	1.66M	11K	9.03K	8.24K
Gross Profit	-377K	-1.66M	-1.66M	-11K	-9.03K	-8.24K
Operating Income	-104.96M	-106.99M	-71.49M	-21.53M	-4.32M	-2.08M
Interest Income	8.32M	2.23M	442K	60K	7K	4K
Pretax Income	-96.66M	-104.79M	-71.1M	-22.12M	-4.32M	-2.2M
Net Income	-96.66M	-102.59M	-70.89M	-22.76M	-4.32M	-2.2M
Selling & General & Admin	18.82M	24.71M	20.39M	7.82M	403K	386K
Research & Development	86.14M	82.27M	51.1M	13.7M	3.92M	1.69M
Other Expenses	n/a	-27K	-47K	n/a	n/a	-31K
Operating Expenses	104.96M	106.99M	71.49M	21.53M	4.32M	2.08M
Interest Expense	n/a	n/a	n/a	653K	n/a	28K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	104.96M	106.99M	71.49M	21.53M	4.32M	2.08M
Income Tax	n/a	-2.2M	-210K	642K	-155.86K	-90K
Shares Outstanding (Basic)	45.25M	40M	39.52M	39.31M	40.17M	14.1M
Shares Outstanding (Diluted)	45.25M	40M	39.52M	39.31M	40.17M	14.1M
EPS (Basic)	-2.14	-2.56	-1.79	-0.58	-0.11	-0.16
EPS (Diluted)	-2.14	-2.56	-1.79	-0.58	-0.11	-0.16
EBITDA	-104.58M	-103.13M	-69.43M	-21.52M	-4.31M	-2.16M
Depreciation & Amortization	377K	1.66M	1.66M	11K	9.03K	8.24K